Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Biotic+ (also known as the Smart Probiotic) is a multi-strain probiotic dietary supplement developed by the UK-based company Heights (Braincare Limited). It is formulated with a combination of seven specific probiotic strains—*Lactobacillus paracasei*, *Lactobacillus rhamnosus*, *Lactobacillus helveticus*, *Bifidobacterium bifidum*, *Lactobacillus rhamnosus GG*, *Bifidobacterium longum*, and the yeast *Saccharomyces boulardii*—delivering 20 billion CFU per capsule. The supplement also contains zinc. Biotic+ is designed to support the gut-brain axis, promoting digestive health, immunity, and indirect mental wellbeing. It utilizes a proprietary delayed-release capsule technology and a protective matrix to ensure the live cultures survive stomach acid and are delivered effectively to the colon.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Biotic+.